Ipilimumab with stereotactic ablative radiation therapy: Phase I results and immunologic correlates from peripheral T-cells

PURPOSE: Little prospective data is available on clinical outcomes and immune correlates from combination radiation and immunotherapy. We conducted a phase I trial (NCT02239900) testing stereotactic ablative radiation therapy (SABR) with ipilimumab. EXPERIMENTAL DESIGN: SABR was given either concurr...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Cancer Res
Main Authors: Tang, Chad, Welsh, James W., de Groot, Patricia, Massarelli, Erminia, Chang, Joe Y., Hess, Kenneth R., Basu, Sreyashi, Curran, Michael A., Cabanillas, Maria E., Subbiah, Vivek, Fu, Siqing, Tsimberidou, Apostolia M., Karp, Daniel, Gomez, Daniel R., Diab, Adi, Komaki, Ritsuko, Heymach, John, Sharma, Padmanee, Naing, Aung, Hong, David
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5355002/
https://ncbi.nlm.nih.gov/pubmed/27649551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-1432
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki